BRWA
SGNT

B. Riley Wealth Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

B. Riley Wealth Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-7,676
Closed -$198K – 2324
2014
Q2 		$198K Sell
7,676
-20,541
-73% -$456K 0.05% 456
2014
Q1 		$659K Sell
28,217
-112,674
-80% -$2.46M 0.2% 121
2013
Q4 		$3.58M Buy
+140,891
New +$3.18M 1.14% 8

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

B. Riley Wealth Advisors's SGNT Position: Q3 2014 in Review

B. Riley Wealth Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2014, closing a stake of 7,676 shares — an estimated $198K sold.

B. Riley Wealth Advisors first reported a position in SGNT in Q4 2013 and held it in 3 quarters. The position peaked at $3.58M in Q4 2013. 114 funds tracked by Wall St. Rank hold SGNT as of Q3 2014.

  • B. Riley Wealth Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 7,676 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $198K.
  • B. Riley Wealth Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2013 and held it in 3 quarters.
  • B. Riley Wealth Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.58M in Q4 2013.
  • 114 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.